Avinger Tigereye CTO Crossing Featured in Live Case at LINC 2021
REDWOOD CITY, CA / ACCESSWIRE / February 3, 2021 / Avinger, Inc. (NASDAQ:AVGR), a commercial-stage medical device company marketing the...
News
Imcyse Enters into Research Collaboration and License Agreement for its Imotope(TM) Technology with Pfizer in Rheumatoid Arthritis
Imcyse and Pfizer to collaborate to develop ImotopeTM candidates to potentially treat Rheumatoid Arthritis Pfizer to lead clinical development and...
Sonnet BioTherapeutics Announces Abstract Accepted for Presentation at AACR 2021 Annual Meeting
PRINCETON, NJ / ACCESSWIRE / February 3, 2021 / Sonnet BioTherapeutics Holdings, Inc., (NASDAQ:SONN) a clinical-stage company developing targeted immunotherapeutic...
Planet 13 Begins Construction of Orange County SuperStore
LAS VEGAS, NV / ACCESSWIRE / February 3, 2020 / Planet 13 Holdings Inc. (CSE:PLTH)(OTCQB:PLNHF) ("Planet 13" or the "Company"),...
Alliance for Regenerative Medicine Responds to EU Beating Cancer Plan
Alliance for Regenerative Medicine Responds to EU Beating Cancer Plan ATMPs are uniquely positioned to attack cancer at its source,...
OPKO Health to Report Fourth Quarter 2020 Financial Results on February 18, 2021
MIAMI, Feb. 03, 2021 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for...
REPEAT – Pure Extracts Announces Submission for Class 1 Natural Product Number (NPN)
VANCOUVER, British Columbia, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure...
Generex Biotechnology Announces Call-in Details and Agenda for Shareholder Conference Call on Friday February 5, 2021 at 9:00 AM
The access information for the investor conference call is as follows: Domestic US/Canada - 1-(866) 342-8588Direct Toll / International -...
Marrone Bio Innovations Issues Shareholder Letter
DAVIS, Calif., Feb. 03, 2021 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (“Marrone Bio”), an international leader in...
Health Professional Resources Launches High-Performance Personal Protective Equipment (PPE) Line in Strategic Partnership with MAS Holdings
U.S.-based health care wholesaler backed by leading global manufacturer behind Nike to bring essential PPE supplies to small and mid-sized...
PDS Biotech Announces Preliminary Efficacy Achievement in Phase 2 Combination Trial of PDS0101 Led by the National Cancer Institute
Full enrollment triggered by observation of 3 objective responses in continued evaluation of the initial group of 8 patientsFLORHAM PARK,...
AXIM® Biotechnologies Begins Clinical Trials on Its ImmunoPass Rapid Diagnostic Test With Vaccine Recipients
SAN DIEGO, Feb. 03, 2021 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech,” “AXIM” or “the Company”), an...
Telo Genomics Retains Former Abbott & Siemens Veteran Gregg Mayer to Lead the Development of the Company’s Industry Partnership Strategy
TORONTO, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Telo Genomics Corp. (TSX-V: TELO) (the “Company” or “TELO”) is pleased to announce...
Nass Valley Gateway Announces It Will Launch Its Newly Renovated Website on February 15th, 2021
January analytics show Nass Valley’s CBD Product Lines are converting at a .57% increase on their e-commerce sites over December’s...
Beroni Acquires Majority Interest in PENAO, an Anti-Cancer Drug Development Company
NEW YORK and SYDNEY, Australia, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Beroni Group (OTCQX: BNIGF; NSX: BTG) (“Beroni”), an Australia-based diversified...
Enzo Announces Issuance of U.S. Patent for Polyclonal Antibodies Against Osteoporosis Drug Target Sclerostin
NEW YORK, NY, Feb. 03, 2021 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE:ENZ) (“Enzo” or the “Company”), a leading biosciences...
InspireMD Secures Partner for Intended Registration and Distribution of CGuard EPS in Mainland China
New Chinese Distributor Will Also Invest in At-The-Market Private PlacementTEL AVIV, Israel, Feb. 03, 2021 (GLOBE NEWSWIRE) -- InspireMD, Inc....
Vaxart Announces Positive Preliminary Data from Phase 1 Clinical Trial Evaluating Its Oral COVID-19 Tablet Vaccine Candidate
Study reached primary and secondary endpoints of safety and immunogenicity, respectivelyVXA-CoV2-1 induced potent CD8+ T-cell responsesVXA-CoV2-1 potentially protective against new...
Oncology Pharma Extends Its Licensing Agreement with NanoSmart Pharmaceuticals, Inc. for Human Oncology
SAN FRANCISCO, CA, Feb. 03, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Oncology Pharma, Inc. (OTC: ONPH) is pleased to...
Casana Raises $14 Million in Series A Funding Led by General Catalyst for In-home Heart Health Monitoring Device
Company funded to develop visionary integrated IoT heart health device, in a toilet seat. Seasoned technology executive Austin McChord takes...